The optic neuritis treatment market is expected to grow at a 4.5% CAGR during the forecast period, rising from US$ 204.97 Million in 2022 to US$ 318.31 Million by 2032.
To remain ‘ahead’ of your competitors, request for a sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-10833
Optic neuritis is an autoimmune disorder which causes inflammation to the optic nerve which transfers visual stimuli to the brain. It is generally found affecting most adults with high predominance in female and also in children affecting either one or both eyes. Optic neuritis may result in loss of vision which may be temporary or permanent. Optic neuritis is often an indication of multiple sclerosis. Certain bacterial infections are the main cause of optic neuritis. Other diseases such as sarcoidosis and systemic autoimmune disorders may also cause optic neuritis. Even some drugs like antibiotics such as tetracycline, ethambutol and isoniazid may also develop optic neuritis. It may lead to a blurry vision of a small area to complete blindness. Generally, it can resolve after treatment but most of the times it reappears. Manufacturers are expected to have growth opportunities in the global optic neuritis treatment market.
Optic Neuritis Treatment Market: Drivers and Restraints
Increasing prevalence of optic neuritis is expected to the leading cause to drive the global optic neuritis treatment market. Increasing incidence of multiple sclerosis can n also be anticipated as a leading growth driver for the global optic neuritis treatment market.
Increased use of prednisolone prednisone and other intravenous steroids is also anticipated to further drive the growth of the global optic neuritis treatment market. Increased incidence of bacterial infections is also anticipated to drive the global optic neuritis treatment market. However, high blood pressure, stomach irritation, weight gain, difficulty in sleeping are some of the side effects associated with systemic steroids which can be anticipated to be the restraint for the growth of the global optic neuritis treatment market.
Avail Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-10833
Optic Neuritis Treatment Market: Overview
The global optic neuritis treatment market is expected to experience steady growth over the forecast period. By disease indication, bacterial infection followed by multiple sclerosis is anticipated to be the leading segment in the global optic neuritis treatment market. By product type, IV steroids (systemic steroids) are anticipated to be the most revenue-generating segment in the global optic neuritis treatment market. Based on the route of administration, Intravenous route is anticipated to be the leading segment in the global optic neuritis treatment market. By distribution channel, retail pharmacies are anticipated to be the most revenue-generating segment in the global optic neuritis treatment market.
Optic Neuritis Treatment Market: Regional Outlook
Globally, optic neuritis treatment market can be segmented into North America, Latin America, Europe, East Asia, Oceania, Middle East and Africa. The global optic neuritis treatment market is expected to be dominated by North America due to increased availability and high adoption of systemic steroids in this region. Europe is expected to be the second most lucrative region in the global optic neuritis treatment market because of increased prevalence of optic neuritis. East Asia is expected to be the fastest-growing in the global optic neuritis treatment market due to large population residing in countries such as China. Latin America is anticipated to experience a steady growth whereas the Middle East and Africa are anticipated to be the least lucrative segments in the global optic neuritis treatment market.
Optic Neuritis Treatment Market: Key Market Participants
Major participants operating the global optic neuritis treatment market are Pfizer Inc., Sanofi Aventis, Henry Schein Inc., Watson Pharmaceuticals, Bristol-Meyers Squibb Co, Novartis AG, Healthy Life Pharma Private Limited, Fresenius Kabi USA LLC, West-Ward Pharmaceuticals, AdvaCarePharma and many other.
Request Report Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-10833
Optic Neuritis Treatment Market: Segmentation
The global optic neuritis treatment market can be segmented on the basis of disease indication, product form, route of administration, product type, by distribution channel and by region.
Based on disease indication, the global optic neuritis treatment market can be segmented as:
• Autoimmune Disorder
• Bacterial Infection
• Multiple Sclerosis
• Drug-Induced Infection
Based on product type, the global optic neuritis treatment market can be segmented as:
- IV Steroids (Systemic Steroids)
• IV Immunoglobulins (Plasma Exchange Therapy)
• Vitamin B12 Shots
• Oral Corticosteroids
Based on the route of administration, the global optic neuritis treatment market can be segmented as:
- Intravenous
• Oral
Based on the distribution channel, the global optic neuritis treatment market can be segmented as:
- Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
